BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28263001)

  • 1. Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation.
    Herrera S; Pérez-López J; Moltó-Abad M; Güerri-Fernández R; Cabezudo E; Novelli S; Esteve J; Hernández A; Roig I; Solanich X; Prieto-Alhambra D; Nogués X; Díez-Pérez A
    J Bone Miner Res; 2017 Jul; 32(7):1575-1581. PubMed ID: 28263001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.
    Herrera S; Soriano R; Nogués X; Güerri-Fernandez R; Grinberg D; García-Giralt N; Martínez-Gil N; Castejón S; González-Lizarán A; Balcells S; Diez-Perez A
    Osteoporos Int; 2017 Dec; 28(12):3489-3493. PubMed ID: 28842728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Material Strength Index as Measured by Impact Microindentation in Postmenopausal Women With Distal Radius and Hip Fractures.
    Rozental TD; Walley KC; Demissie S; Caksa S; Martinez-Betancourt A; Parker AM; Tsai JN; Yu EW; Bouxsein ML
    J Bone Miner Res; 2018 Apr; 33(4):621-626. PubMed ID: 29115684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact microindentation in men with impaired fasting glucose and type 2 diabetes.
    Holloway-Kew KL; Betson A; Rufus-Membere PG; Gaston J; Diez-Perez A; Kotowicz MA; Pasco JA
    Bone; 2021 Jan; 142():115685. PubMed ID: 33049369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Density, Microarchitecture, and Tissue Quality Long-term After Kidney Transplant.
    Pérez-Sáez MJ; Herrera S; Prieto-Alhambra D; Nogués X; Vera M; Redondo-Pachón D; Mir M; Güerri R; Crespo M; Díez-Pérez A; Pascual J
    Transplantation; 2017 Jun; 101(6):1290-1294. PubMed ID: 27467533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature.
    Schoeb M; Hamdy NAT; Malgo F; Winter EM; Appelman-Dijkstra NM
    Front Endocrinol (Lausanne); 2020; 11():15. PubMed ID: 32117052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Khan A; Hangartner T; Weinreb NJ; Taylor JS; Mistry PK
    J Bone Miner Res; 2012 Aug; 27(8):1839-48. PubMed ID: 22692814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.
    Gervas-Arruga J; Cebolla JJ; de Blas I; Roca M; Pocovi M; Giraldo P
    PLoS One; 2015; 10(5):e0126153. PubMed ID: 25978039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on bone microarchitecture and failure load in a patient with type I Gaucher disease who switched from Imiglucerase to Eliglustat.
    Sidhu K; Boyd SK; Khan A
    Mol Genet Metab Rep; 2020 Sep; 24():100606. PubMed ID: 32509532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.
    Mistry PK; Weinreb NJ; Kaplan P; Cole JA; Gwosdow AR; Hangartner T
    Blood Cells Mol Dis; 2011 Jan; 46(1):66-72. PubMed ID: 21112800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ; Kacena KA; Kaplan P; Pastores GM; Prakash-Cheng A; Zimran A; Hangartner TN
    J Bone Miner Res; 2007 Jan; 22(1):119-26. PubMed ID: 17032149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A High Amount of Local Adipose Tissue Is Associated With High Cortical Porosity and Low Bone Material Strength in Older Women.
    Sundh D; Rudäng R; Zoulakis M; Nilsson AG; Darelid A; Lorentzon M
    J Bone Miner Res; 2016 Apr; 31(4):749-57. PubMed ID: 26588353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM; Elstein D; Hrebícek M; Zimran A
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase.
    Bondar C; Mucci J; Crivaro A; Ormazabal M; Ceci R; Oliveri B; González D; Rozenfeld P
    Bone; 2017 Oct; 103():262-269. PubMed ID: 28736246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between Bone Impact Microindentation and Clinical Risk Factors for Fracture.
    Rufus-Membere P; Holloway-Kew KL; Diez-Perez A; Kotowicz MA; Pasco JA
    Endocrinology; 2019 Sep; 160(9):2143-2150. PubMed ID: 31310275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
    Schoeb M; Winter EM; Malgo F; Schipper IB; van der Wal RJP; Papapoulos SE; Appelman-Dijkstra NM
    Osteoporos Int; 2022 Jul; 33(7):1511-1519. PubMed ID: 35307747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments of osteoporosis increase bone material strength index in patients with low bone mass.
    Schoeb M; Malgo F; Peeters JJM; Winter EM; Papapoulos SE; Appelman-Dijkstra NM
    Osteoporos Int; 2020 Sep; 31(9):1683-1690. PubMed ID: 32270252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normative Data for Impact Microindentation for Australian Men: Cross-Sectional Data From the Geelong Osteoporosis Study.
    Rufus-Membere P; Holloway-Kew KL; Kotowicz MA; Diez-Perez A; Pasco JA
    JBMR Plus; 2020 Sep; 4(9):e10384. PubMed ID: 32995688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 Diabetes Mellitus Is Associated With Better Bone Microarchitecture But Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population-Based Study.
    Nilsson AG; Sundh D; Johansson L; Nilsson M; Mellström D; Rudäng R; Zoulakis M; Wallander M; Darelid A; Lorentzon M
    J Bone Miner Res; 2017 May; 32(5):1062-1071. PubMed ID: 27943408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone tissue quality in patients with monoclonal gammopathy of uncertain significance.
    Orduna G; Mellibovsky L; Abella E; Nogués X; Granero R; García-Giralt N; Pineda-Moncusí M; Güerri-Fernández R; Prieto-Alhambra D; Díez-Pérez A
    J Bone Miner Metab; 2020 Jul; 38(4):563-569. PubMed ID: 31974675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.